Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,098.2
-

 

  • STI Straits Times Index
    3,098.2
    -
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,496.9
    -
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,658.9
    -
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,576.9
    -
    Index delayed 15 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 0.3M
  • Value: 0.7M
  • Rise: -
  • Fall: -
  • Unch: 761

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
QT Vascular0.006-
Golden Agri-Res0.225-0.010
Singtel2.370-0.030
HGH0.020-
Medtecs Intl0.435+0.030
CapLand IntCom T2.090-0.010
Mapletree Log Tr1.860-0.010
MarcoPolo Marine0.027-0.001
ComfortDelGro1.370-0.010
Sembcorp Marine0.084-

World Indices

World Indices
Name Last Change
Nasdaq 15,537.7 -245.1
HSI 23,658.9
HSCEI 8,426.2
Jakarta 6,507.7
Nikkei 225 27,935.6
SSE Comp 3,576.9
Shanghai A 3,748.9
Shanghai B 281.7
KOSPI 2,888.0 -11.7

Nikkei 225 updated at end-of-day. Other Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

SI BONE INC SI-BONE
Updated on 30 Nov 2021 (End of trading day)
Last (USD): 19.250 Change: -0.070 High: 19.950 Remarks: -
Change (%): -0.36 Low: 18.710

Company Background

SI-BONE, Inc. engages in the provision of implantable devices used in the surgical treatment of the sacropelvic anatomy. It offers a proprietary minimally invasive surgical implant system, called iFuse, used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in Santa Clara, CA.

Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.30479 Trailing EPS (USD) b -1.52506 NAV (USD) c 4.2884
PE a - Trailing PE d - Price / NAV c 4.4889
Dividend Yield (%) e - Cash In Hand (USD) f 1.7875 Issued & Paid-up Shares g 33,489,800
Piotroski F Score 3 Market Cap (M) 644.679 Free Float (%) 84.1
Return on Equity (ROE) (%) h n.m. Revenue Growth (%) TTM i 22.535
Net Earnings Growth (%) j -16.565 Net Debt/Equity k Net Cash
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted based on Profit Attributable To Shareholders.
  2. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  3. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  4. Based on latest Full Year results announcement, adjusted for the current number of shares.
  5. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  6. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  7. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 11 Nov 2021. Please click here for more information.
  8. Calculated based on Net Earnings / (Shareholders' Equity - Other Share Capital)
  9. Calculated based on (Current Year Revenue - Last Year Revenue) / Last Year Revenue
  10. Calculated based on (Current Year Earnings - Last Year Earnings) / Last Year Earnings
  11. Calculated based on (Long Term Debt + Short Term Debt - Cash and Short Term Investments)/(Shareholders' Equity - Other Share Capital)

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --1.790
-8.51 %
10 Days --3.290
-14.60 %
20 Days --4.760
-19.83 %
Medium Term Return 3 Months --5.530
-22.32 %
6 Months --10.150
-34.52 %
1 Year --3.970
-17.10 %
Long Term Return 2 Years -+1.470
+8.27 %
3 Years --0.150
-0.77 %
Annualised Return Annualised --
-0.26 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference SI BONE INC NASDAQ 644.679 - - 4.4889 -
Industry Medical Specialties NASDAQ 3,064.631 132.723 135.231 8.4933 0.025
Local Peer INTUITIVE SURGICAL INC NASDAQ 115,780.298 109.165 68.541 10.1465 -
Local Peer DEXCOM INC NASDAQ 54,527.348 110.469 103.018 25.5266 -
Local Peer IDEXX LABORATORIES INC NASDAQ 51,560.444 88.626 68.124 68.3140 -
Local Peer ALIGN TECHNOLOGY INC NASDAQ 48,221.036 27.153 65.159 13.7118 -
Local Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 25,308.757 34.784 54.871 7.6291 -
Local Peer INSULET CORPORATION NASDAQ 19,892.928 2,925.355 - 39.9535 -
Local Peer HOLOGIC INC NASDAQ 18,788.691 10.039 10.039 4.4538 -
Local Peer MASIMO CORPORATION NASDAQ 15,358.259 63.912 66.183 10.4609 -
Local Peer ABIOMED INC NASDAQ 14,321.420 63.503 96.019 10.3436 -
Local Peer BRUKER CORPORATION NASDAQ 12,282.538 77.836 45.440 11.4193 0.198
Local Peer DENTSPLY SIRONA INC NASDAQ 10,654.905 - 25.521 2.0802 0.821
Local Peer NOVOCURE LTD NASDAQ 9,721.611 490.801 - 23.5294 -
Other Local Peers TANDEM DIABETES CARE INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), INMODE LTD (NASDAQ), SOTERA HEALTH CO (NASDAQ), QUIDEL CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), ICU MEDICAL INC (NASDAQ), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), STAAR SURGICAL CO (NASDAQ), LIVANOVA PLC (NASDAQ), NEOGEN CORP (NASDAQ), THE BEAUTY HEALTH COMPANY (NASDAQ), INARI MEDICAL INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), ATRICURE INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), AXONICS INC (NASDAQ), NUVASIVE INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), OUTSET MEDICAL INC (NASDAQ), CAREDX INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), HESKA CORP (NASDAQ), VERICEL CORP (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), CUE HEALTH INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), PROCEPT BIOROBOTICS CORP (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), ATRION CORP (NASDAQ), PULMONX CORPORATION (NASDAQ), CERUS CORP (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), VIEWRAY INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), BIOVENTUS INC (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), SIGHT SCIENCES INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), INTERCURE LTD (NASDAQ), INOGEN INC (NASDAQ), CUTERA INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), AIRSCULPT TECHNOLOGIES INC (NASDAQ), SEMLER SCIENTIFIC INC (NASDAQ), 908 DEVICES INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), SURMODICS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), DERMTECH INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ANTARES PHARMA INC (NASDAQ), IRADIMED CORP (NASDAQ), NYXOAH SA (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), ACCURAY INCORPORATED (NASDAQ), SOLITON INC (NASDAQ), ZYNEX INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), AXOGEN INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), AVITA MEDICAL INC (NASDAQ), PAVMED INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), LUCID DIAGNOSTICS INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), NEUROPACE INC (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), LUCIRA HEALTH INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), CVRX INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), SIENTRA INC (NASDAQ), PROFOUND MED CORP (NASDAQ), EARGO INC (NASDAQ), ONCOCYTE CORP (NASDAQ), QUOTIENT LTD (NASDAQ), CYTOSORBENTS CORP (NASDAQ), CORMEDIX INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), MINERVA SURGICAL INC (NASDAQ), TELA BIO INC (NASDAQ), CONFORMIS INC (NASDAQ), ICECURE MEDICAL LTD (NASDAQ), INTRICOM CORP (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), FONAR CORP (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), NEURONETICS INC (NASDAQ), CRYO-CELL INTERNATIONAL INC (NASDAQ), IRIDEX CORP (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), CHECK-CAP LTD (NASDAQ), TITAN MEDICAL INC (NASDAQ), LENSAR INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), NEPHROS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), IMMUCELL CORP (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), BIOLASE INC (NASDAQ), ENVVENO MED CORP (NASDAQ), BIOMERICA INC (NASDAQ), CELSION CORPORATION (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), AVINGER INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), ELECTROCORE INC (NASDAQ), NUTRIBAND INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), NEOVASC INC (NASDAQ), NEUROMETRIX INC (NASDAQ), APPLIED UV INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), BLUEJAY DIAGNOSTICS INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), KEWAUNEE SCIENTIFIC CORP (NASDAQ), TIVIC HEALTH SYSTEMS INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), HEARTBEAM INC (NASDAQ), INSPIREMD INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), PETVIVO HLDGS INC (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), DYNATRONICS CORP (NASDAQ), CYANOTECH CORP (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), NUWELLIS INC (NASDAQ), STAR EQUITY HOLDINGS INC (NASDAQ)
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 246,733.155 38.703 28.807 6.3739 0.141
Global Peer DANAHER CORP NYSE 228,464.558 65.090 39.927 5.6856 0.224
Global Peer ABBOTT LABORATORIES NYSE 224,113.075 50.104 31.075 6.5107 1.209
Global Peer STRYKER CORP NYSE 90,198.084 56.409 47.473 6.3618 0.982
Global Peer BECTON DICKINSON & CO NYSE 68,640.080 34.286 34.286 2.8993 1.393
Global Peer EDWARDS LIFESCIENCES CORP NYSE 67,072.202 81.457 45.402 12.1041 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 54,349.119 - 52.158 3.3015 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 45,571.800 - 37.663 8.4564 0.514
Global Peer ALCON AG NYSE 39,176.480 - 118.001 2.0519 0.133
Global Peer BAXTER INTERNATIONAL INC NYSE 37,336.677 33.881 30.755 4.2573 1.291
Other Global Peers RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), PERKINELMER INC (NYSE), STERIS PLC (NYSE), BIO RAD LABORATORIES INC (NYSE), WATERS CORP (NYSE), COOPER COS INC (NYSE), SMITH & N